Active Pharmaceutical Ingredient Market Report

China Active Pharmaceutical Ingredient Industry Market Research Report 2023-2029

  • POSTDATE：Aug 21, 2023
  • PAGES：135
  • REPORT CODE：GMM1748492
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Active Pharmaceutical Ingredient industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Huahai Pharmaceutical

    • Zhejiang Medicine

    • BASF

    • Novartis

    • Cipla

    • Albemarle

    • Biocon

    • Mylan

    • Boehringer Ingelheim GmbH

    • Jiangsu Hengrui Medicine

    • DSM

    • Aurobindo pharma

    • Johnson & Johnson

    • Shandong Lukang Pharmaceutical

    • Lonza group

    • North China Pharmaceutical Group

    • Johnson Matthey

    • Hisun Pharmacy

    • North East Pharmaceutical

    • Haerbin Pharmaceutical Group

    • Shandong Xinhua Pharmaceutical

    • Pfizer

    • Roche

    • Sun Pharmaceutical Industries

    • Cambrex

    • Tian Yao

    • Teva

    By Type:

    • Biotech Active Pharmaceutical Ingredient

    • Synthetic Active Pharmaceutical Ingredient

    • Other

    By Application:

    • Cardiovascular Drugs

    • Central Nervous System Drugs (CNS Drugs)

    • Non-steroidal Anti-inflammatory Drugs (NSAIDs)

    • Other Drugs

    • Musculoskeletal Drugs

    • Anti-diabetic Drugs

    • Oncology Drugs

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Active Pharmaceutical Ingredient Market Overview 2018-2029

    • 1.1 China Active Pharmaceutical Ingredient Industry Development Overview

    • 1.2 China Active Pharmaceutical Ingredient Industry Development History

    • 1.3 China Active Pharmaceutical Ingredient Industry Market Size (2018-2029)

    • 1.4 China Active Pharmaceutical Ingredient Market Analysis by Type from Production Side

      • 1.4.1 China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Biotech Active Pharmaceutical Ingredient (2018-2029)

      • 1.4.2 China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Synthetic Active Pharmaceutical Ingredient (2018-2029)

      • 1.4.3 China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China Active Pharmaceutical Ingredient Market Analysis by Application from Consumption End

      • 1.5.1 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Cardiovascular Drugs (2018-2029)

      • 1.5.2 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Central Nervous System Drugs (CNS Drugs) (2018-2029)

      • 1.5.3 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2018-2029)

      • 1.5.4 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Other Drugs (2018-2029)

      • 1.5.5 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Musculoskeletal Drugs (2018-2029)

      • 1.5.6 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Anti-diabetic Drugs (2018-2029)

      • 1.5.7 China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Oncology Drugs (2018-2029)

    • 1.6 China Active Pharmaceutical Ingredient Market Analysis by Region

      • 1.6.1 North China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    Chapter 2 China Active Pharmaceutical Ingredient Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Active Pharmaceutical Ingredient Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Active Pharmaceutical Ingredient Market Status and Competition Analysis in 2023

      • 2.2.3 China Active Pharmaceutical Ingredient Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Active Pharmaceutical Ingredient Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredient Industry Development

    Chapter 3 Active Pharmaceutical IngredientIndustry Chain Analysis

    • 3.1 Active Pharmaceutical Ingredient Industry Chain

    • 3.2 Active Pharmaceutical Ingredient Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Active Pharmaceutical Ingredient Market

    • 3.3 Active Pharmaceutical Ingredient Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Active Pharmaceutical Ingredient Market

    Chapter 4 China Active Pharmaceutical Ingredient Market, by Type

    • 4.1 China Active Pharmaceutical Ingredient Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Active Pharmaceutical Ingredient Total Production Volume and Growth Rate from Production Side

    • 4.5 China Active Pharmaceutical Ingredient Production Volume and Growth Rate, by Type

      • 4.5.1 China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Biotech Active Pharmaceutical Ingredient

      • 4.5.2 China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Synthetic Active Pharmaceutical Ingredient

      • 4.5.3 China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Other

    Chapter 5 China Active Pharmaceutical Ingredient Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Active Pharmaceutical Ingredient Total Market Size and Growth Rate from Consumption End

    • 5.5 China Active Pharmaceutical Ingredient Market Size and Growth Rate, by Application

      • 5.5.1 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Cardiovascular Drugs

      • 5.5.2 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Central Nervous System Drugs (CNS Drugs)

      • 5.5.3 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs)

      • 5.5.4 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Other Drugs

      • 5.5.5 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Musculoskeletal Drugs

      • 5.5.6 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Anti-diabetic Drugs

      • 5.5.7 China Active Pharmaceutical Ingredient Market Size and Growth Rate of Oncology Drugs

    Chapter 6 China Active Pharmaceutical Ingredient Market, by Region

    • 6.1 China Active Pharmaceutical Ingredient Production Volume and Production Value, by Region

    • 6.2 China Active Pharmaceutical Ingredient Sales Volume and Sales Value, by Region

    Chapter 7 North China Active Pharmaceutical Ingredient Market Analysis

    • 7.1 North China Active Pharmaceutical Ingredient Market, by Type

    • 7.2 North China Active Pharmaceutical Ingredient Market, by Application

    Chapter 8 Central China Active Pharmaceutical Ingredient Market Analysis

    • 8.1 Central China Active Pharmaceutical Ingredient Market, by Type

    • 8.2 Central China Active Pharmaceutical Ingredient Market, by Application

    Chapter 9 South China Active Pharmaceutical Ingredient Market Analysis

    • 9.1 South China Active Pharmaceutical Ingredient Market, by Type

    • 9.2 South China Active Pharmaceutical Ingredient Market, by Application

    Chapter 10 East China Active Pharmaceutical Ingredient Market Analysis

    • 10.1 East China Active Pharmaceutical Ingredient Market, by Type

    • 10.2 East China Active Pharmaceutical Ingredient Market, by Application

    Chapter 11 Northeast China Active Pharmaceutical Ingredient Market Analysis

    • 11.1 Northeast China Active Pharmaceutical Ingredient Market, by Type

    • 11.2 Northeast China Active Pharmaceutical Ingredient Market, by Application

    Chapter 12 Southwest China Active Pharmaceutical Ingredient Market Analysis

    • 12.1 Southwest China Active Pharmaceutical Ingredient Market, by Type

    • 12.2 Southwest China Active Pharmaceutical Ingredient Market, by Application

    Chapter 13 Northwest China Active Pharmaceutical Ingredient Market Analysis

    • 13.1 Northwest China Active Pharmaceutical Ingredient Market, by Type

    • 13.2 Northwest China Active Pharmaceutical Ingredient Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Huahai Pharmaceutical

        • 14.1.1 Huahai Pharmaceutical Company Profile

        • 14.1.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Zhejiang Medicine

        • 14.2.1 Zhejiang Medicine Company Profile

        • 14.2.2 Zhejiang Medicine Active Pharmaceutical Ingredient Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 BASF

        • 14.3.1 BASF Company Profile

        • 14.3.2 BASF Active Pharmaceutical Ingredient Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis

        • 14.4.1 Novartis Company Profile

        • 14.4.2 Novartis Active Pharmaceutical Ingredient Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Cipla

        • 14.5.1 Cipla Company Profile

        • 14.5.2 Cipla Active Pharmaceutical Ingredient Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Albemarle

        • 14.6.1 Albemarle Company Profile

        • 14.6.2 Albemarle Active Pharmaceutical Ingredient Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Biocon

        • 14.7.1 Biocon Company Profile

        • 14.7.2 Biocon Active Pharmaceutical Ingredient Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Mylan

        • 14.8.1 Mylan Company Profile

        • 14.8.2 Mylan Active Pharmaceutical Ingredient Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Boehringer Ingelheim GmbH

        • 14.9.1 Boehringer Ingelheim GmbH Company Profile

        • 14.9.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Jiangsu Hengrui Medicine

        • 14.10.1 Jiangsu Hengrui Medicine Company Profile

        • 14.10.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 DSM

        • 14.11.1 DSM Company Profile

        • 14.11.2 DSM Active Pharmaceutical Ingredient Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Aurobindo pharma

        • 14.12.1 Aurobindo pharma Company Profile

        • 14.12.2 Aurobindo pharma Active Pharmaceutical Ingredient Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Johnson & Johnson

        • 14.13.1 Johnson & Johnson Company Profile

        • 14.13.2 Johnson & Johnson Active Pharmaceutical Ingredient Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Shandong Lukang Pharmaceutical

        • 14.14.1 Shandong Lukang Pharmaceutical Company Profile

        • 14.14.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Lonza group

        • 14.15.1 Lonza group Company Profile

        • 14.15.2 Lonza group Active Pharmaceutical Ingredient Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 North China Pharmaceutical Group

        • 14.16.1 North China Pharmaceutical Group Company Profile

        • 14.16.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Johnson Matthey

        • 14.17.1 Johnson Matthey Company Profile

        • 14.17.2 Johnson Matthey Active Pharmaceutical Ingredient Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Hisun Pharmacy

        • 14.18.1 Hisun Pharmacy Company Profile

        • 14.18.2 Hisun Pharmacy Active Pharmaceutical Ingredient Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 North East Pharmaceutical

        • 14.19.1 North East Pharmaceutical Company Profile

        • 14.19.2 North East Pharmaceutical Active Pharmaceutical Ingredient Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Haerbin Pharmaceutical Group

        • 14.20.1 Haerbin Pharmaceutical Group Company Profile

        • 14.20.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Shandong Xinhua Pharmaceutical

        • 14.21.1 Shandong Xinhua Pharmaceutical Company Profile

        • 14.21.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Pfizer

        • 14.22.1 Pfizer Company Profile

        • 14.22.2 Pfizer Active Pharmaceutical Ingredient Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Roche

        • 14.23.1 Roche Company Profile

        • 14.23.2 Roche Active Pharmaceutical Ingredient Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 Sun Pharmaceutical Industries

        • 14.24.1 Sun Pharmaceutical Industries Company Profile

        • 14.24.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 Cambrex

        • 14.25.1 Cambrex Company Profile

        • 14.25.2 Cambrex Active Pharmaceutical Ingredient Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Tian Yao

        • 14.26.1 Tian Yao Company Profile

        • 14.26.2 Tian Yao Active Pharmaceutical Ingredient Market Performance

        • 14.26.3 Product&Service Introduction

      • 14.27 Teva

        • 14.27.1 Teva Company Profile

        • 14.27.2 Teva Active Pharmaceutical Ingredient Market Performance

        • 14.27.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Active Pharmaceutical Ingredient Industry Research Conclusions

    • 15.2 Active Pharmaceutical Ingredient Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Active Pharmaceutical Ingredient Industry Market Size (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Biotech Active Pharmaceutical Ingredient (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Synthetic Active Pharmaceutical Ingredient (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Cardiovascular Drugs (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Central Nervous System Drugs (CNS Drugs) (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Other Drugs (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Musculoskeletal Drugs (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Anti-diabetic Drugs (2018-2029)

    • Figure China Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Oncology Drugs (2018-2029)

    • Figure North China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Central China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure South China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure East China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Active Pharmaceutical Ingredient Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Active Pharmaceutical Ingredient Market Share by Type in 2018

    • Figure China Active Pharmaceutical Ingredient Market Share by Type in 2023

    • Figure China Active Pharmaceutical Ingredient Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Biotech Active Pharmaceutical Ingredient (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Synthetic Active Pharmaceutical Ingredient (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Share by Application in 2018

    • Figure China Active Pharmaceutical Ingredient Market Share by Application in 2023

    • Figure China Active Pharmaceutical Ingredient Total Market Size and Growth Rate from Consumption End

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Cardiovascular Drugs (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Central Nervous System Drugs (CNS Drugs) (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Other Drugs (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Musculoskeletal Drugs (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Anti-diabetic Drugs (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Market Size and Growth Rate of Oncology Drugs (2018-2023)

    • Table China Active Pharmaceutical Ingredient Production Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Production Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Production Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Production Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Production Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Production Value Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Sales Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Sales Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Sales Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Sales Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredient Sales Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredient Sales Value Share by Region (2018-2023)

    • Table North China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure North China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table North China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure North China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure South China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure South China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure East China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure East China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Huahai Pharmaceutical Company Profile

    • Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Zhejiang Medicine Company Profile

    • Table Zhejiang Medicine Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table BASF Company Profile

    • Table BASF Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Cipla Company Profile

    • Table Cipla Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Albemarle Company Profile

    • Table Albemarle Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Hengrui Medicine Company Profile

    • Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table DSM Company Profile

    • Table DSM Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Aurobindo pharma Company Profile

    • Table Aurobindo pharma Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Shandong Lukang Pharmaceutical Company Profile

    • Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Lonza group Company Profile

    • Table Lonza group Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table North China Pharmaceutical Group Company Profile

    • Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Johnson Matthey Company Profile

    • Table Johnson Matthey Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Hisun Pharmacy Company Profile

    • Table Hisun Pharmacy Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table North East Pharmaceutical Company Profile

    • Table North East Pharmaceutical Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Haerbin Pharmaceutical Group Company Profile

    • Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Shandong Xinhua Pharmaceutical Company Profile

    • Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Industries Company Profile

    • Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Cambrex Company Profile

    • Table Cambrex Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Tian Yao Company Profile

    • Table Tian Yao Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US